Integrium Appoints Michael Gleeson As Chief Executive Officer
10/19/2005 5:10:30 PM
TUSTIN, Calif.--(BUSINESS WIRE)--May 5, 2005--Integrium, a contract research organization (CRO), announced the appointment of Michael Gleeson to the position of chief executive officer, formerly held by Dr. David Smith - one of Integrium's founding partners. Smith will continue in a key role at Integrium by focusing on the company's medical affairs and pharmacovigilance services.
Gleeson is responsible for further establishing Integrium as a premier CRO for biopharmaceutical and medical device companies. He will ensure the continued growth and expansion of Integrium, and will strategically position the company's operations and service offerings to meet continually changing industry needs. Gleeson brings extensive leadership, operations, and business development experience to Integrium from his 35+ years in the healthcare industry.
comments powered by